Estados Unidos

Clemens M. Schirmer, MD, PhD, MBA, FAANS, FACS, FAHA earned his medical degree and a doctorate in medical research from Ludwig-Maximilians University in Munich and Harvard Medical School under the auspices of the Harvard-Munich Alliance for Medical Education. He completed a residency in neurosurgery and a fellowship in Interventional Neuroradiology at Tufts Medical Center in Boston. He completed the TRIUM global MBA program, jointly awarded by the London School of Economics, Ecole des Hautes etudes commercials de Paris (HEC), and New York University Stern School of Business.
ABNS board-certified in Neurological surgery he holds subspecialty board recognition of focused practice (RFP) certificates in Neuroendovascular surgery and Neurocritical care. He currently serves as Vice-Chair in the Department of Neurosurgery and Program Director of the Geisinger Neurosurgery residency training program and the CAST Neuroendovascular Fellowship program. He is a full Professor of Neurosurgery and Neuroscience in the unmodified research track at the Geisinger Commonwealth School of Medicine and serves as System Director of the Geisinger Comprehensive Stroke Centers and the Division of Cerebrovascular and Endovascular Neurosurgery.
His research focuses on the quality and variation of care, shared decision-making, genomics, stroke biomarkers, machine learning, and data analytics. He serves as the principal investigator of numerous clinical trials exploring stroke and cerebrovascular questions and is leading Geisinger initiatives such as ProvenCare and Stroke prevention.
He is involved in organized medicine and neurosurgery as chair of the AANS/CNS Joint Cerebrovascular Section, executive committee member of the Congress of Neurological Surgeons, co-chair of the Development Committee and Co-Editor of the CongressQuarterly, CNS foundation board member, chair of the public relations and communications subcommittee of the Joint Washington Committee and advisor to the AMA RBRVS RUC committee. He has been appointed to MEDCAC and multiple CMS/Acumen Measure Development Panels.